Categoría: Stem Cell Therapy
-
US FDA Green Lights Second Duchenne’s Muscular Dystrophy Patient To Receive Human Umbilical Cord Stem Cells In US
(PRWEB) MAY 26, 2016 After several promising treatments in Panama using stem cell technology developed by Medistem Panama Inc. at the City of Knowledge in Panama, a 6 year-old Duchenne’s muscular dystrophy patient received his first umbilical cord tissue-derived mesenchymal stem cells in the US earlier this year following FDA approval of a second application…
-
New article concludes US FDA restrictions hampering stem cell therapy progress
An article published this month in Thieme Journal of Knee Surgery entitled, «The Use of Biologic Agents in Athletes with Knee Injuries» concluded that «Biologic agents… are becoming the mainstay of nonoperative therapy in the high-demand athletic population.» but «…Unfortunately, strict regulations by the FDA continue to restrict their application in clinical practice.» The good…
-
Why Stem Cells Work: Clinical Trials for Spinal Cord Injury, Multiple Sclerosis, Rheumatoid Arthritis, and Duchenne’s Muscular Dystrophy
—
por
en Bone Marrow Stem Cells, Clinical Trials, Duchenne’s muscular dystrophy, Duchenne’s muscular dystrophy, Medistem Labs Panama, Mesenchymal Stem Cells, Multiple Sclerosis, muscular dystrophy, Muscular Dystrophy, Neil Riordan PA PhD, News, Rheumatoid Arthritis, Spinal Cord Injury, Stem Cell Lecture Videos, Stem Cell Research, Stem Cell Therapy, umbilical cord tissue stem cellsNeil Riordan, PhD speaks at the Riordan-McKenna Institute and Stem Cell Institute fall seminar in Southlake, Texas on October 10, 2015. Dr. Riordan discusses: How our lab selects uses specialized screening techniques to select only the stem cells that we know will be the most useful for our patients. Only about 1 in 100 cords…
-
What are the sources of the stem cells used at Stem Cell Institute in Panama?
Lately, especially on our Facebook Page many people are asking us, «What is the source of the stem cells?» At the Stem Cell Institute, we use two types of stem cells. Primarily, we use allogeneic mesenchymal stem cells harvested from human umbilical cord tissue. In addition to allogeneic mesenchymal stem cells, our spinal cord injury…
-
Stem Cells Targeting Inflammation as Potential Anti-aging Strategies and Therapies
Rafael Gonzalez, Dave Woynarowski and Luis Geffner The use of stem cells as anti-aging therapies may offer many an alternative method of slowing down or deterring several of the detrimental aspects of aging Abstract Human aging is associated with a vast array of clinical disorders that all relate to the body’s inability to maintain homeostasis.…